InterCure Begins 2022 with Record Breaking First Quarter Financial Results

Written by Customer Service on May 16, 2022. Posted in Earnings Releases And Operating Results.

Quarterly revenues Quarterly revenues Record revenue of $341 million in the first quarter of 2022 Adjusted EBITDA2 increased almost 110% year-over-year to $8 million Net income of $6 million for the Q1 of 2022 compared to $2 million in Q1 of 2021 Seventh consecutive quarter of positive cash flow from operations $91 million cash on March 31, 2022 Revenue growth expected to continue in the second quarter and throughout 2022 NEW YORK and TORONTO and HERZLIYA, Israel , May 16, 2022 (GLOBE NEWSWIRE) — InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)(“InterCure” or the “Company”) is pleased to announced its financial results for the first quarter of 2022 and is pleased to provide shareholders with a business update. All amounts are expressed in Canadian dollars ($)3 or New Israeli Shekels (NIS), unless...

ABVC Biopharma Reports First Quarter 2022 Financial and Operational Results

Written by Customer Service on May 16, 2022. Posted in Earnings Releases And Operating Results.

FREMONT, CA, May 16, 2022 (GLOBE NEWSWIRE) — via NewMediaWire—ABVC BioPharma, Inc. (Nasdaq: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced its financial and operating results for the first quarter of 2022. First Quarter 2022 Financial Results All comparisons are made on a year-over-year basis. Revenues. The Company generated $25,660 and $263,150 in revenues for the three months ended March 31, 2022 and 2021, respectively. The decrease in revenues was mainly due to the impact of COVID-19 on the Contract Development & Manufacturing Organization (“CDMO”) business sector. Operating Expenses increased by $4,727,835 to $6,242,485 for the three months ended March 31, 2022 from $1,514,650 for the three months ended March 31,...

Firm Capital Property Trust Starts 2022 With Strong Quarterly Acquisitions, Earnings and Financing Growth and $8.27/Unit NAV

Written by Customer Service on May 16, 2022. Posted in Earnings Releases And Operating Results.

$99 Million of Announced Acquisitions since the Beginning of 2022$82 Million of Capital Raising Activities$8.27/Unit NAV TSX Graduation TORONTO, May 16, 2022 (GLOBE NEWSWIRE) — Firm Capital Property Trust (“FCPT” or the “Trust”), (TSX: FCD.UN) is pleased to report its financial results for the three months ended March 31, 2022. PROPERTY PORTFOLIO HIGHLIGHTSThe portfolio consists of 66 commercial properties with a total gross leasable area (“GLA”) of 2,453,963 square feet, five multi-residential complexes comprised of 599 units and two Manufactured Home Communities comprised of 423 units. The portfolio is well diversified and defensive in terms of geographies and property asset types, with 55% of NOI (43% of asset value) comprised of grocery anchored retail followed by industrial at 28% of NOI (21% of asset value). TENANT DIVERSIFICATIONThe...

Skylight Health Group Reports First Quarter 2022 Financial Results

Written by Customer Service on May 16, 2022. Posted in Earnings Releases And Operating Results.

Revenue Growth of 255% Year over Year and Entry into Full-Risk in 2022 TORONTO, May 16, 2022 (GLOBE NEWSWIRE) — Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, today announced its financial results for the first quarter ended March 31, 2022. Strong revenue growth of 255% Year over Year through the continued acquisition of primary care practices. Accelerates its 3-5 year journey to Medicare Advantage (“MA”) full risk into 2022 with the acquisition of NeighborMD (“NMD”) and the joint venture (“JV”) with Collaborative Health Systems (“CHS”). Over $70 million revenue run rate on a proforma basis with the acquisition of NMD and before any revenue synergies from new MA contracts within current practices. Closes a US $20 million...

Nevada Copper Achieves Key Development Milestones: Paste Plant Commissioning Underway, First Paste Filled Stope; Open Pit Resource Definition Drilling Program Commenced

Written by Customer Service on May 16, 2022. Posted in Earnings Releases And Operating Results.

Announces Filing of Q1 2022 Financial Report; Management Changes YERINGTON, Nev., May 16, 2022 (GLOBE NEWSWIRE) — Nevada Copper (TSX: NCU) (OTC: NEVDF) (FSE: ZYTA) (“Nevada Copper” or the “Company”) today announced its first quarter 2022 financial and operating results as well as recent milestone achievements and updates on key development initiatives for its Pumpkin Hollow underground mine (the “Underground Mine”) and open pit project (the “Open Pit Project”). The Company has filed its interim financial statements and the related management’s discussion and analysis (“MD&A”) for the quarter ended March 31, 2022 with the Canadian securities regulatory authorities, which documents can be accessed under the Company’s profile on www.SEDAR.com. Recent Developments Underground Mine Ramp Up Continues: Underground production continues...

CAPREIT Reports Continued Solid Performance in First Quarter of 2022

Written by Customer Service on May 16, 2022. Posted in Earnings Releases And Operating Results.

TORONTO, May 16, 2022 (GLOBE NEWSWIRE) — Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX: CAR.UN) announced today continuing strong operating and financial results for the three months ended March 31, 2022. HIGHLIGHTS: For the Three Months Ended March 31, 2022 2021 Portfolio Performance Overall portfolio occupancy (1) 98.0 % 97.3 % Overall portfolio net Average Monthly Rents (1), (2) $ 1,159 $ 1,115 Operating revenues (000s) $ 246,628 $ 227,506 Net Operating Income (“NOI”) (000s) $ 153,172 $ 146,652 NOI margin 62.1 % 64.5 % Financial Performance Normalized Funds from Operations (“NFFO”) (000s) (3) $ 97,622 $ 95,942 NFFO per Unit – basic (3) $ 0.556 $ 0.556 Cash distributions per...

Telecure Technologies Inc. Provides Update on the Filings of its Audited Financial Statements and Related Management Cease Trade Order

Written by Customer Service on May 16, 2022. Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, May 16, 2022 (GLOBE NEWSWIRE) — Telecure Technologies Inc. (“TELE” or the “Company”) (CSE: TELE) on May 2, 20222, announced a delay in the filing of its audited annual financial statements and management discussion & analysis for the financial years ended December 31, 2021 and 2020, and the CEO and CFO certificates, all as required by National Instrument 51-102 – Continuous Disclosure Obligations and National Instrument 52-109 – Certification of Disclosure in Issuers’ Annual and Interim Filings (collectively, the “Filings”). The Filings were required to be made with the relevant securities regulatory authorities on or before May 2, 2022. The delay of the Filings is due to fact that the Company is having difficulty accessing various documents and ‎information ‎required in order to respond...

AnPac Bio Reports Fiscal Year 2021 Annual Financial Results

Written by Customer Service on May 16, 2022. Posted in Earnings Releases And Operating Results.

PHILADELPHIA, May 16, 2022 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today its annual financial results for the year ended December 31, 2021. Financial Highlights for Fiscal Year 2021 Total revenues were RMB18.0 million (US$2.8 million) in fiscal year 2021, a decrease of 12.3% from RMB20.5 million (US$3.1 million) in fiscal year 2020. Gross margin was 68.1% in fiscal year 2021, an increase of 5.3% from 62.8% in fiscal year 2020. The average selling price (“ASP”) of CDA-based tests was RMB387 (US$61) in fiscal year 2021, a decrease of RMB58, or 13.2% from RMB446 in fiscal year 2020, primarily due to focusing on more conventional cancer detection tests at lower prices. Net loss increased...

Petros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

Written by Customer Service on May 16, 2022. Posted in Earnings Releases And Operating Results.

NEW YORK, May 16, 2022 (GLOBE NEWSWIRE) — Petros Pharmaceuticals, Inc. (“Petros” or “the Company”) (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, today announced financial results for the first quarter ended March 31, 2022. Recent Highlights: Announced the pursuit of the 505(b)(2) pathway for early stage asset, H-100 for the treatment of Peyronie’s Disease Initiated sponsored research agreement with Massachusetts General Hospital to evaluate incorporating the use of a tissue-specific oxygenation sensor with the goal of monitoring and understanding the success of Erectile Device Therapy. Reported positive results of a Phase 2 label comprehension study to initiate process for STENDRA® prescription erectile dysfunction medication to support the process for designation as over -the-counter treatment Engaged...

Global Crossing Airlines First Quarter 2022 Update

Written by Customer Service on May 16, 2022. Posted in Earnings Releases And Operating Results.

Q1 Quarter Highlights Total Revenue hours flown were 33% over Q4 2021 and total revenue increased 46% Currently have $70M in signed contracts or LOI’S for 2022 and still projecting $90+ Million in revenue for 2022 To date, $76 Million in signed contracts and LOI’S for 2023 and $52 million for 2024 Signed long-term lease for two Airbus A321 freighter aircraft Aerovista to be delivered in August 2023 and November 2023 bringing total A321F aircraft under lease or commitment to 20 freighter aircraft Filed Form 8-A Registration and became a fully reporting SEC Issuer Agreed to a partnership with OSM Aviation Academy to implement a Pilot Direct Placement Training program, creating a robust pipeline of new pilots Closed US$6.0 million Financing Signed LOI for up to 200 electric vertical take-off and landing (eVTOL) aircraft with EVE Mobility...

Day: May 16, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice